| Literature DB >> 26331337 |
Marie C Heffern1, Viktorie Reichova1, Joseph L Coomes1, Allison S Harney1, Elizabeth A Bajema1, Thomas J Meade1.
Abstract
Cobalt(III) Schiff base complexes ([Co(acacen)(L)2](+), where L = NH3) inhibit histidine-containing proteins through dissociative exchange of the labile axial ligands (L). This work investigates axial ligand exchange dynamics of [Co(acacen)(L)2](+) complexes toward the development of protein inhibitors that are activated by external triggers such as light irradiation. We sought to investigate ligand exchange dynamics to design a Co(III) complex that is substitutionally inert under normal physiological conditions for selective activation. Fluorescent imidazoles (C3Im) were prepared as axial ligands in [Co(acacen)(L)2](+) to produce complexes (CoC3Im) that could report on ligand exchange and, thus, complex stability. These fluorescent imidazole reporters guided the design of a new dinuclear Co(III) Schiff base complex containing bridging diimidazole ligands, which exhibits enhanced stability to ligand exchange with competing imidazoles and to hydrolysis within a biologically relevant pH range. These studies inform the design of biocompatible Co(III) Schiff base complexes that can be selectively activated for protein inhibition with spatial and temporal specificity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26331337 PMCID: PMC4638226 DOI: 10.1021/acs.inorgchem.5b01415
Source DB: PubMed Journal: Inorg Chem ISSN: 0020-1669 Impact factor: 5.165